Identification of novel germline and somatic mutations associated with hepatocellular carcinoma by next-generation sequencing
Frontiers in Pharmacology · 06.01.2026 · 16
DOI: 10.3389/fphar.2025.1699280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 06.01.2026. Verfasst von Ahmed Baligh Laaribi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microorganisms and Active Biomolecules (LR03ES03), Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis, Tunisia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-associated deaths worldwide with an estimated of 900,000 new cases annually. HCC typically arises in patients with chronic liver disease, including hepatitis, cirrhosis, and non-alcoholic fatty liver diseases. Identifying of the main driver genetic alterations in oncogenic genes is essential for understanding HCC pathogenesis and defining prognostic biomarkers in high-risk patients. This study aimed to identify both germline and somatic mutations associated with HCC in a Tunisian patient’s cohort.
Methods
Forty HCC patients with different etiologies were included in this study. Peripheral blood samples were collected from 24 patients with advanced-stage HCC. Paired tumor and adjacent non-tumoral liver tissue samples were obtained from 16 early-stage HCC patients undergoing hepatic resection, including 10 fresh-frozen samples and 6 FFPE samples. DNA was extracted using the MagCore® Plus II system. Targeted next-generation sequencing was performed using the Illumina AmpliSeq™ Cancer Hotspot Panel v2 .
Results
A total of 35 germline mutations were identified across 25 genes. Recurrently altered genes included FGFR3 (100%), PDGFRA (100%), RET (98%), APC (92%), TP53 (88%), and EGFR (75%). In addition, 14 somatic mutations were detected in 13 genes, with frequent alterations observed in APC (100%), ALK (94%), HNF1A (56%), CDKN2A (50%), and HRAS (50%).
Conclusion
This study offers the first comprehensive overview of novel germline and somatic mutations in Tunisian HCC patients, representing a North African cohort, and highlights key molecular drivers of hepatocarcinogenesis. These findings support the integration of genetic profiling into clinical practice to enhance early diagnosis and guide personalized therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Microorganisms and Active Biomolecules (LR03ES03), Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis, Tunisia.
- Common Sequencing Unite, Faculty of Sciences of Tunis, Department of Biology, University of Tunis El Manar, Tunis, Tunisia.
- Department of Gastroenterology, University Hospital of Mongi Slim, La Marsa, Tunisia.
- Department of Pathology Anatomy, University Hospital of Mongi Slim, La Marsa, Tunisia.
- Department of General Surgery and Liver Transplantation, University Hospital of Mongi Slim, La Marsa, Tunisia.
Zitieren
APA
Laaribi, A. B., Babay, W., Lekired, A., Bouchabou, B., Mehri, A., Bacha, D., Sassi, R., Ben Slama, S., Bayar, R., Omrani, S., Boujelbene, N., Ennaifer, R., Arfa, N., Lahmar, A., & Ouzari, H. I. (2026). Identification of novel germline and somatic mutations associated with hepatocellular carcinoma by next-generation sequencing. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1699280
Vancouver
Laaribi AB, Babay W, Lekired A, Bouchabou B, Mehri A, Bacha D, et al. Identification of novel germline and somatic mutations associated with hepatocellular carcinoma by next-generation sequencing. Frontiers in Pharmacology. 2026;16. doi:10.3389/fphar.2025.1699280
BibTeX
@article{Laaribi2026,
author = {Laaribi, Ahmed Baligh and Babay, Wafa and Lekired, Abdelmalek and Bouchabou, Bochra and Mehri, Asma and Bacha, Dhouha and Sassi, Riadh and Ben Slama, Sana and Bayar, Rached and Omrani, Sahir and Boujelbene, Nadia and Ennaifer, Rim and Arfa, Nafaa and Lahmar, Ahlem and Ouzari, Hadda-Imene},
title = {Identification of novel germline and somatic mutations associated with hepatocellular carcinoma by next-generation sequencing},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {16},
doi = {10.3389/fphar.2025.1699280}
}
EUVIMED